A milestone has been reached
After an intensive and targeted work, the cell line development of our lead drug candidate SOL-116 has been finalized. Now the production optimization and scale up has been initiated and that will provide access of non-GMP and GMP material during 2020. That will enable toxicity studies and start of clinical trials as planned during 2021.Read the article from Biostock here (in swedish) >
How pleasant it is to travel on a familiar route! The landscape of memories glides past as the train moves along the rusty track. In business, however, the old rusty track seldom leads to the desired goal. While you may get the train on the move and people on board, there’s no guarantee when you set off that you’ll get to your destination.You need new milestones, alternative routes and more speed. But above all, you need the courage to move away from the familiar track and start building new routes towards new goals, which are now a mere glimmer on the horizon.
The significance of
The Biogas Market Investigation’s proposals that were submitted to the Swedish Government December 18, would ensure competitive conditions for biogas produced in Sweden and a growing demand for biogas. This is the assessment of the energy company Gasum, which owns a total of 13 biogas production plants in the Nordics.Biogas producers in Sweden have long experienced a distorted competitive playing field compared to Denmark, where producers enjoy extensive production support. At the same time, growing amounts of biogas imported from Denmark have had positive effects since the use of biogas in
